Subject has adequate organ and marrow function.
6. Adequate organ and marrow function;
Adequate organ and marrow function
Adequate organ and marrow function
Must have adequate organ and marrow function
Subjects with adequate organ and marrow function
Adequate organ and marrow function as defined below:
Have adequate normal organ and marrow function, including the following:
The patient has adequate organ and marrow function as follows:
Adequate organ and marrow function
Patients must have adequate organ and marrow function as determined by the treating oncologist
Subjects must have adequate organ and marrow at screening as defined below:
The patient has adequate organ and marrow function per protocol
Adequate organ and marrow function
Adequate normal organ and marrow function
Adequate organ and marrow function as determined by medical oncology evaluation
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function, defined per protocol
Adequate organ and marrow function
Adequate organ and marrow function
Subjects must have adequate organ and marrow function as defined below:
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function , as defined below:
Adequate organ and marrow function.
Adequate organ and marrow function.
Patients must have adequate organ and marrow function as defined below
Adequate organ and marrow function
Adequate organ and marrow function
Acceptable organ and marrow function ?21 days prior to registration:
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function
For all tumor types, adequate organ and marrow function, as defined below:
Adequate organ and marrow function:
Adequate organ and marrow function
Adequate organ and marrow function
Patients are eligible regardless of organ/marrow function
Participants must have adequate organ and marrow function to proceed to transplant
Adequate organ and marrow function.
Participants must have organ and marrow function within the following parameters within 16 weeks before Segment B enrollment:
No organ and marrow function requirements
No restrictions will be made based on organ or marrow function
Requirements for organ and marrow function are not applicable to this study, but function will need to be sufficient to undergo planned therapy
No requirements for organ and marrow function
The patient has adequate organ and marrow function as follows:
Adequate organ and marrow function
